RUNX3 and gastric cancer: Kim et al. found that RUNX3 CpG island methylation occured in 8.1 % of chronic gastritis cases, 28.1 % of intestinal metaplasia cases, 27.3 % of gastric adenocarcinoma cases, 64 % of primary gastric cancer cases, and 60 % of gastric cancer cell lines [19].